Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination

Detalles Bibliográficos
Autores principales: Gattringer, Thomas, Gressenberger, Paul, Gary, Thomas, Wölfler, Albert, Kneihsl, Markus, Raggam, Reinhard Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899650/
https://www.ncbi.nlm.nih.gov/pubmed/34244449
http://dx.doi.org/10.1136/svn-2021-001142
_version_ 1784663958945267712
author Gattringer, Thomas
Gressenberger, Paul
Gary, Thomas
Wölfler, Albert
Kneihsl, Markus
Raggam, Reinhard Bernd
author_facet Gattringer, Thomas
Gressenberger, Paul
Gary, Thomas
Wölfler, Albert
Kneihsl, Markus
Raggam, Reinhard Bernd
author_sort Gattringer, Thomas
collection PubMed
description
format Online
Article
Text
id pubmed-8899650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88996502022-03-22 Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination Gattringer, Thomas Gressenberger, Paul Gary, Thomas Wölfler, Albert Kneihsl, Markus Raggam, Reinhard Bernd Stroke Vasc Neurol Letter BMJ Publishing Group 2021-07-08 /pmc/articles/PMC8899650/ /pubmed/34244449 http://dx.doi.org/10.1136/svn-2021-001142 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Gattringer, Thomas
Gressenberger, Paul
Gary, Thomas
Wölfler, Albert
Kneihsl, Markus
Raggam, Reinhard Bernd
Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
title Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
title_full Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
title_fullStr Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
title_full_unstemmed Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
title_short Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
title_sort successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after chadox1 ncov-19 vaccination
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899650/
https://www.ncbi.nlm.nih.gov/pubmed/34244449
http://dx.doi.org/10.1136/svn-2021-001142
work_keys_str_mv AT gattringerthomas successfulmanagementofvaccineinducedimmunethromboticthrombocytopeniarelatedcerebralsinusvenousthrombosisafterchadox1ncov19vaccination
AT gressenbergerpaul successfulmanagementofvaccineinducedimmunethromboticthrombocytopeniarelatedcerebralsinusvenousthrombosisafterchadox1ncov19vaccination
AT garythomas successfulmanagementofvaccineinducedimmunethromboticthrombocytopeniarelatedcerebralsinusvenousthrombosisafterchadox1ncov19vaccination
AT wolfleralbert successfulmanagementofvaccineinducedimmunethromboticthrombocytopeniarelatedcerebralsinusvenousthrombosisafterchadox1ncov19vaccination
AT kneihslmarkus successfulmanagementofvaccineinducedimmunethromboticthrombocytopeniarelatedcerebralsinusvenousthrombosisafterchadox1ncov19vaccination
AT raggamreinhardbernd successfulmanagementofvaccineinducedimmunethromboticthrombocytopeniarelatedcerebralsinusvenousthrombosisafterchadox1ncov19vaccination

Ejemplares similares